_id
69131466ccc777a4e85d7ff9
Ticker
MDNAF
Name
Medicenna Therapeutics Corp
Exchange
OTCQX
Address
2 Bloor Street West, Toronto, ON, Canada, M4W 3E2
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.medicenna.com
Description
Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a tumor-targeting and activatable masked anti-PD-1-IL-2 BiSKITTM for cancer; and MDNA132, an IL-13 Superkine for various tumors. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
Last Close
0.7
Volume
23000
Current Price
0.667
Change
0.053
Last Updated
2026-01-05T10:17:48.481Z
Image
data:image/webp;base64,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
Ipo Date
2001-08-27T00:00:00.000Z
Market Cap
60556700
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.75
Target Price
3.25
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
5470000
Operating Income
-5470000
Interest Expense
-
Pretax Income
-4883000
Net Income
-4883000
Eps
-0.05854113407831912
Dividends Per Share
-
Shares Outstanding
83411435
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
429000
Cash
15748000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
17872000
Property Plant Equipment
120000
Total Assets
18041000
Payables
3646000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
7799000
Equity
10242000
Bs_currency_symbol
CAD
Depreciation
23000
Change In Working Capital
-122000
Cash From Operations
-4937000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-19000
Net Change In Cash
-4711000
Cf_currency_symbol
CAD
PE
-
PB
5.432086227787542
ROE
-47.67623511033001
ROA
-27.066127154814033
FCF
-4937000
Fcf Percent
-
Piotroski FScore
0
Health Score
33
Deep Value Investing Score
3
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
5470000
Quarters > 0 > income Statement > operating Income
-5470000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-4883000
Quarters > 0 > income Statement > net Income
-4883000
Quarters > 0 > income Statement > eps
-0.05854113407831912
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
83411435
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
429000
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
15748000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
17872000
Quarters > 0 > balance Sheet > property Plant Equipment
120000
Quarters > 0 > balance Sheet > total Assets
18041000
Quarters > 0 > balance Sheet > payables
3646000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7799000
Quarters > 0 > balance Sheet > equity
10242000
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-4883000
Quarters > 0 > cash Flow > depreciation
23000
Quarters > 0 > cash Flow > change In Working Capital
-122000
Quarters > 0 > cash Flow > cash From Operations
-4937000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-19000
Quarters > 0 > cash Flow > net Change In Cash
-4711000
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.05854113407831912
Quarters > 0 > ratios > PB
5.432086227787542
Quarters > 0 > ratios > ROE
-47.67623511033001
Quarters > 0 > ratios > ROA
-27.066127154814033
Quarters > 0 > ratios > FCF
-4937000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
33
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
5509000
Quarters > 1 > income Statement > operating Income
-5509000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-4928000
Quarters > 1 > income Statement > net Income
-4928000
Quarters > 1 > income Statement > eps
-0.05910239201580413
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
83380720
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
377000
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
20459000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
22578000
Quarters > 1 > balance Sheet > property Plant Equipment
142000
Quarters > 1 > balance Sheet > total Assets
22770000
Quarters > 1 > balance Sheet > payables
3187000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
8129000
Quarters > 1 > balance Sheet > equity
14641000
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-4928000
Quarters > 1 > cash Flow > depreciation
19000
Quarters > 1 > cash Flow > change In Working Capital
1343000
Quarters > 1 > cash Flow > cash From Operations
-3546000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
39000
Quarters > 1 > cash Flow > net Change In Cash
-4378000
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.05910239201580413
Quarters > 1 > ratios > PB
3.7985752503244314
Quarters > 1 > ratios > ROE
-33.65890308039069
Quarters > 1 > ratios > ROA
-21.642512077294686
Quarters > 1 > ratios > FCF
-3546000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
5719000
Quarters > 2 > income Statement > operating Income
-5719000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
1187000
Quarters > 2 > income Statement > net Income
1187000
Quarters > 2 > income Statement > eps
0.015175974501805807
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
78215735
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
6642000
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
24837000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
28171000
Quarters > 2 > balance Sheet > property Plant Equipment
159000
Quarters > 2 > balance Sheet > total Assets
28382000
Quarters > 2 > balance Sheet > payables
2701000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
9287000
Quarters > 2 > balance Sheet > equity
19095000
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
1187000
Quarters > 2 > cash Flow > depreciation
19000
Quarters > 2 > cash Flow > change In Working Capital
963000
Quarters > 2 > cash Flow > cash From Operations
-4996000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-19000
Quarters > 2 > cash Flow > net Change In Cash
-5159000
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
0.015175974501805807
Quarters > 2 > ratios > PB
2.732123343545431
Quarters > 2 > ratios > ROE
6.216286986122022
Quarters > 2 > ratios > ROA
4.182228172785568
Quarters > 2 > ratios > FCF
-4996000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
66
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
5120000
Quarters > 3 > income Statement > operating Income
-5120000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-5191000
Quarters > 3 > income Statement > net Income
-5191000
Quarters > 3 > income Statement > eps
-0.06636771999905135
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
78215735
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-449000
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
29996000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
32011000
Quarters > 3 > balance Sheet > property Plant Equipment
175000
Quarters > 3 > balance Sheet > total Assets
32239000
Quarters > 3 > balance Sheet > payables
1880000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
14788000
Quarters > 3 > balance Sheet > equity
17451000
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-5191000
Quarters > 3 > cash Flow > depreciation
18000
Quarters > 3 > cash Flow > change In Working Capital
540000
Quarters > 3 > cash Flow > cash From Operations
-3555000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1908000
Quarters > 3 > cash Flow > net Change In Cash
-430000
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.06636771999905135
Quarters > 3 > ratios > PB
2.989507492120796
Quarters > 3 > ratios > ROE
-29.746146352644548
Quarters > 3 > ratios > ROA
-16.10161605508856
Quarters > 3 > ratios > FCF
-3555000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
20406000
Annuals > 0 > income Statement > operating Income
-20406000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-11805000
Annuals > 0 > income Statement > net Income
-11805000
Annuals > 0 > income Statement > eps
-0.15092871018855733
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
78215735
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
7251000
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
24837000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
28171000
Annuals > 0 > balance Sheet > property Plant Equipment
159000
Annuals > 0 > balance Sheet > total Assets
28382000
Annuals > 0 > balance Sheet > payables
2701000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
9287000
Annuals > 0 > balance Sheet > equity
19095000
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-11805000
Annuals > 0 > cash Flow > depreciation
53000
Annuals > 0 > cash Flow > change In Working Capital
1314000
Annuals > 0 > cash Flow > cash From Operations
-16492000
Annuals > 0 > cash Flow > capital Expenditures
33000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
23492000
Annuals > 0 > cash Flow > net Change In Cash
7855000
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.15092871018855733
Annuals > 0 > ratios > PB
2.9860838342498033
Annuals > 0 > ratios > ROE
-61.822466614296935
Annuals > 0 > ratios > ROA
-41.59326333591713
Annuals > 0 > ratios > FCF
-16525000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
35
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
18674000
Annuals > 1 > income Statement > operating Income
-18674000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-25466000
Annuals > 1 > income Statement > net Income
-25466000
Annuals > 1 > income Statement > eps
-0.3656939341089493
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
69637469
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-7990000
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
16982000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
19077000
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
19134000
Annuals > 1 > balance Sheet > payables
2070000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
13943000
Annuals > 1 > balance Sheet > equity
5191000
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-25466000
Annuals > 1 > cash Flow > depreciation
4000
Annuals > 1 > cash Flow > change In Working Capital
741000
Annuals > 1 > cash Flow > cash From Operations
-16260000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
0
Annuals > 1 > cash Flow > net Change In Cash
-16614000
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.3656939341089493
Annuals > 1 > ratios > PB
9.779563648815257
Annuals > 1 > ratios > ROE
-490.57984973993445
Annuals > 1 > ratios > ROA
-133.0929235915125
Annuals > 1 > ratios > FCF
-16260000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
12
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
16303000
Annuals > 2 > income Statement > operating Income
-16303000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-10048000
Annuals > 2 > income Statement > net Income
-10048000
Annuals > 2 > income Statement > eps
-0.1442901378279558
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
69637469
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
5341000
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
33596000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
36385000
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
36446000
Annuals > 2 > balance Sheet > payables
1617000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
6960000
Annuals > 2 > balance Sheet > equity
29486000
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-10048000
Annuals > 2 > cash Flow > depreciation
4000
Annuals > 2 > cash Flow > change In Working Capital
2410000
Annuals > 2 > cash Flow > cash From Operations
-12657000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
24760000
Annuals > 2 > cash Flow > net Change In Cash
13061000
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
-0.1442901378279558
Annuals > 2 > ratios > PB
1.7216887641931764
Annuals > 2 > ratios > ROE
-34.077189174523504
Annuals > 2 > ratios > ROA
-27.56955495802009
Annuals > 2 > ratios > FCF
-12657000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
22473000
Annuals > 3 > income Statement > operating Income
-22473000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-22577000
Annuals > 3 > income Statement > net Income
-22577000
Annuals > 3 > income Statement > eps
-0.40571469553903783
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
55647479
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-173000
Annuals > 3 > income Statement > currency_symbol
CAD
Annuals > 3 > balance Sheet > cash
20535000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
23391000
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
23456000
Annuals > 3 > balance Sheet > payables
1672000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2621000
Annuals > 3 > balance Sheet > equity
20835000
Annuals > 3 > balance Sheet > currency_symbol
CAD
Annuals > 3 > cash Flow > net Income
-22577000
Annuals > 3 > cash Flow > depreciation
38000
Annuals > 3 > cash Flow > change In Working Capital
-1844000
Annuals > 3 > cash Flow > cash From Operations
-23584000
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
3878000
Annuals > 3 > cash Flow > net Change In Cash
-9840000
Annuals > 3 > cash Flow > currency_symbol
CAD
Annuals > 3 > ratios > PE
-0.40571469553903783
Annuals > 3 > ratios > PB
1.9470608203023756
Annuals > 3 > ratios > ROE
-108.36093112550995
Annuals > 3 > ratios > ROA
-96.2525579809004
Annuals > 3 > ratios > FCF
-23584000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
35
Valuation > metrics > PE
-0.05854113407831912
Valuation > metrics > PB
5.432086227787542
Valuation > final Score
25.679137722124583
Valuation > verdict
81.1% Overvalued
Profitability > metrics > ROE
-47.67623511033001
Profitability > metrics > ROA
-27.32206803939123
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.7614723686779926
Risk > metrics > Interest Coverage
-12.750582750582751
Risk > final Score
-3
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.90181020296215
Liquidity > metrics > Quick Ratio
4.90181020296215
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
42.01424749675569
Prev Valuations > 1
100
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
40
Prev Profitabilities > 2
15
Prev Risks > 0
-10
Prev Risks > 1
57
Prev Risks > 2
2
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:11:29.089Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-12
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.047
Earnings History > 0 > eps Difference
0.047
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-13
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0428
Earnings History > 1 > eps Estimate
-0.0456
Earnings History > 1 > eps Difference
0.0028
Earnings History > 1 > surprise Percent
6.1404
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-07-31
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.06
Earnings History > 2 > eps Estimate
-0.0436
Earnings History > 2 > eps Difference
-0.0164
Earnings History > 2 > surprise Percent
-37.6147
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-06-25
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
CAD
Earnings History > 3 > eps Actual
0.0146
Earnings History > 3 > eps Estimate
-0.036
Earnings History > 3 > eps Difference
0.0506
Earnings History > 3 > surprise Percent
140.5556
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-12
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
CAD
Earnings History > 4 > eps Actual
-0.0489
Earnings History > 4 > eps Estimate
-0.0477
Earnings History > 4 > eps Difference
-0.0012
Earnings History > 4 > surprise Percent
-2.5157
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-12
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.0357
Earnings History > 5 > eps Estimate
-0.04
Earnings History > 5 > eps Difference
0.0043
Earnings History > 5 > surprise Percent
10.75
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-02
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
-0.04
Earnings History > 6 > eps Estimate
-0.04
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
0
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-06-27
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.2
Earnings History > 7 > eps Estimate
-0.05
Earnings History > 7 > eps Difference
-0.15
Earnings History > 7 > surprise Percent
-300
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-14
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.07
Earnings History > 8 > eps Estimate
-0.07
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-14
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.05
Earnings History > 9 > eps Estimate
-0.07
Earnings History > 9 > eps Difference
0.02
Earnings History > 9 > surprise Percent
28.5714
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-07-28
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
-0.04
Earnings History > 10 > eps Estimate
-0.06
Earnings History > 10 > eps Difference
0.02
Earnings History > 10 > surprise Percent
33.3333
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
-0.04
Earnings History > 11 > eps Estimate
-0.07
Earnings History > 11 > eps Difference
0.03
Earnings History > 11 > surprise Percent
42.8571
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-08
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.0149
Earnings History > 12 > eps Estimate
-0.01
Earnings History > 12 > eps Difference
-0.0049
Earnings History > 12 > surprise Percent
-49
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-11
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.0074
Earnings History > 13 > eps Estimate
-0.01
Earnings History > 13 > eps Difference
0.0026
Earnings History > 13 > surprise Percent
26
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-12
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.0514
Earnings History > 14 > eps Estimate
-0.05
Earnings History > 14 > eps Difference
-0.0014
Earnings History > 14 > surprise Percent
-2.8
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-13
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.0464
Earnings History > 15 > eps Estimate
-0.05
Earnings History > 15 > eps Difference
0.0036
Earnings History > 15 > surprise Percent
7.2
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-09
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.071
Earnings History > 16 > eps Estimate
-0.07
Earnings History > 16 > eps Difference
-0.001
Earnings History > 16 > surprise Percent
-1.4286
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-12
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.1194
Earnings History > 17 > eps Estimate
-0.12
Earnings History > 17 > eps Difference
0.0006
Earnings History > 17 > surprise Percent
0.5
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-13
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.0959
Earnings History > 18 > eps Estimate
-0.1
Earnings History > 18 > eps Difference
0.0041
Earnings History > 18 > surprise Percent
4.1
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-28
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-0.0879
Earnings History > 19 > eps Estimate
-0.09
Earnings History > 19 > eps Difference
0.0021
Earnings History > 19 > surprise Percent
2.3333
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-02-11
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-0.0867
Earnings History > 20 > eps Estimate
-0.09
Earnings History > 20 > eps Difference
0.0033
Earnings History > 20 > surprise Percent
3.6667
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-03
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
CAD
Earnings History > 21 > eps Actual
-0.0608
Earnings History > 21 > eps Estimate
-0.06
Earnings History > 21 > eps Difference
-0.0008
Earnings History > 21 > surprise Percent
-1.3333
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-04
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
CAD
Earnings History > 22 > eps Actual
-0.05
Earnings History > 22 > eps Estimate
-0.04
Earnings History > 22 > eps Difference
-0.01
Earnings History > 22 > surprise Percent
-25
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-15
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
CAD
Earnings History > 23 > eps Actual
-0.07
Earnings History > 23 > eps Estimate
-0.04
Earnings History > 23 > eps Difference
-0.03
Earnings History > 23 > surprise Percent
-75
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-02-13
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
CAD
Earnings History > 24 > eps Actual
-0.07
Earnings History > 24 > eps Estimate
-0.07
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
0
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-05
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
CAD
Earnings History > 25 > eps Actual
-0.07
Earnings History > 25 > eps Estimate
-0.07
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
0
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-09
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
CAD
Earnings History > 26 > eps Actual
-0.05
Earnings History > 26 > eps Estimate
-0.08
Earnings History > 26 > eps Difference
0.03
Earnings History > 26 > surprise Percent
37.5
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-06-25
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
CAD
Earnings History > 27 > eps Actual
-0.03
Earnings History > 27 > eps Estimate
-0.11
Earnings History > 27 > eps Difference
0.08
Earnings History > 27 > surprise Percent
72.7273
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-02-14
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
CAD
Earnings History > 28 > eps Actual
-0.0522
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-11-13
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
CAD
Earnings History > 29 > eps Actual
-0.0279
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-08-13
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
CAD
Earnings History > 30 > eps Actual
-0.0327
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-06-27
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
CAD
Earnings History > 31 > eps Actual
-0.05
Earnings History > 31 > eps Estimate
-0.11
Earnings History > 31 > eps Difference
0.06
Earnings History > 31 > surprise Percent
54.5455
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-02-12
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
CAD
Earnings History > 32 > eps Actual
-0.09
Earnings History > 32 > eps Estimate
-0.14
Earnings History > 32 > eps Difference
0.05
Earnings History > 32 > surprise Percent
35.7143
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-11-13
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
AfterMarket
Earnings History > 33 > currency
CAD
Earnings History > 33 > eps Actual
-0.0563
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a tumor-targeting and activatable masked anti-PD-1-IL-2 BiSKITTM for cancer; and MDNA132, an IL-13 Superkine for various tumors. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACancer drug MDNA11 shows 50% response rate as Medicenna maps 2026 trials Stock Titan
Read more →Medicenna (OTCQX: MDNAF) to host MDNA11 ABILITY-1 data webinar with live Q&A Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$3.25
Analyst Picks
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Medicenna Therapeutics Corp
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.047
Date
2025-09-30
EPS Actual
-0.0428
EPS Estimate
-0.0456
EPS Difference
0.0028
Surprise Percent
6.1404%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.